Spine Subdural Hematoma: a Rare Complication Associated with Vitamin K Antagonist (VKA)

被引:1
作者
Prync Flato, Uri Adrian [1 ]
机构
[1] Hosp Villa Lobos, Sao Paulo, Brazil
关键词
Hematoma; subdural spinal; spinal cord; blood coagulation; ATRIAL-FIBRILLATION; RISK-FACTORS; STROKE; ANTICOAGULATION; MANAGEMENT; WARFARIN; THERAPY;
D O I
10.1590/S0066-782X2009000100013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Spinal subdural hematoma (SSDH) is a rare condition, which is difficult to diagnose, related to Vitamin K Antagonist. This a case report of a life-threatening situation in a octogenarian patient with a history of recent atrial fibrillation that received K-Vitamin Antagonist (KVA) therapy. The history and the clinical assessment were normal at the admission, associated with increase in the coagulation parameters (INR > 10). Twenty-four hours after the admission, the patient developed progressive tetraparesis and a Magnetic Resonance Imaging (MRI) was performed, disclosing the evidence of a SSDH (Figure 1). An emergency neurosurgical intervention was performed associated with normalization of the coagulation parameters. After the procedure, the patient presented improvement of the neurological symptoms.
引用
收藏
页码:E1 / E3
页数:3
相关论文
共 10 条
[1]   Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic [J].
Abdelhafiz, AH ;
Wheeldon, NM .
CLINICAL THERAPEUTICS, 2004, 26 (09) :1470-1478
[2]   Pharmacology and management of the vitamin K antagonists [J].
Ansell, Jack ;
Hirsh, Jack ;
Hylek, Elaine ;
Jacobson, Alan ;
Crowther, Mark ;
Palareti, Gualtiero .
CHEST, 2008, 133 (06) :160S-198S
[3]   Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin [J].
Beyth, RJ ;
Quinn, LM ;
Landefeld, CS .
AMERICAN JOURNAL OF MEDICINE, 1998, 105 (02) :91-99
[4]  
Braun P, 2005, EUR J RADIOL EXTRA, V55, P5
[5]   Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study [J].
Go, AS ;
Hylek, EM ;
Phillips, KA ;
Chang, YC ;
Henault, LE ;
Selby, JV ;
Singer, DE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18) :2370-2375
[6]  
Gutiérrez SP, 1999, NEURORADIOLOGY, V41, P910
[7]   Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation [J].
Hart, Robert G. ;
Pearce, Lesly A. ;
Aguilar, Maria I. .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (08) :590-592
[8]  
LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449
[9]  
POST MJD, 1994, AM J NEURORADIOL, V15, P1895
[10]   Hemorrhagic complications of anticoagulant and thrombolytic treatment [J].
Schulman, Sam ;
Beyth, Rebecca J. ;
Kearon, Clive ;
Levine, Mark N. .
CHEST, 2008, 133 (06) :257S-298S